Key Takeaways BPC-157 reduces inflammation markers by up to 60% and may help repair damaged reproductive tissue TB-500 shows promise in reducing endometrial adhesions and fibrosis formation Peptide therapy targets root inflammatory causes rather than just masking pain symptoms Clinical evidence suggests 40-50% pain reduction when peptides are used with conventional treatment Medical supervision is essential as peptide therapy for endometriosis remains investigational in 2026 Understanding Endometriosis and Inflammation Endometriosis affects approximately 10% of reproductive-age women and creates chronic inflammation throughout the pelvic cavity
However, only about a half of newly generated cells survive in the long term to integrate in the preexisting neural network, and a subgroup of these neurons will show abnormal morpho-functional development, including aberrant migration, bipolar morphology, or an abnormal functional development
Perovic D, Milavic M, Dokuzovic S, Krezic I, Gojkovic S, Vranes H, et al
For IBS, BPC-157 alleviates abdominal pain and bloating through its anti-inflammatory properties
The modulation of N -methyl-d-aspartate receptors by redox and alkylating reagents in rat cortical neurones in vitro